These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1187 related items for PubMed ID: 28637502

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E, Trofimiuk-Müldner M, Wysocka K, Pach D, Kiełtyka A, Stefańska A, Sowa-Staszczak A, Tomaszewska R, Hubalewska-Dydejczyk A.
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [Abstract] [Full Text] [Related]

  • 7. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
    Panzuto F, Merola E, Pavel ME, Rinke A, Kump P, Partelli S, Rinzivillo M, Rodriguez-Laval V, Pape UF, Lipp R, Gress T, Wiedenmann B, Falconi M, Delle Fave G.
    Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
    Wang X, Song ZF, Yao WX, Pan CC, Xiang MF, Wang H.
    Zhonghua Yi Xue Za Zhi; 2013 May 14; 93(18):1411-4. PubMed ID: 24025507
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T, Ito T, Komoto I, Uemoto S, JNETS Project Study Group.
    BMC Cancer; 2020 Nov 14; 20(1):1104. PubMed ID: 33189127
    [Abstract] [Full Text] [Related]

  • 12. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
    Shi H, Zhang Q, Han C, Zhen D, Lin R.
    BMC Endocr Disord; 2018 Jul 28; 18(1):51. PubMed ID: 30055596
    [Abstract] [Full Text] [Related]

  • 13. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
    Ptasnuka M, Ozolins A, Narbuts Z, Truskovs A, Sperga M, Plaudis H.
    World J Surg; 2020 Feb 28; 44(2):585-593. PubMed ID: 31605174
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
    Madani A, Thomassen I, van Gestel YRBM, van der Bilt JDW, Haak HR, de Hingh IHJT, Lemmens VEPP.
    Ann Surg Oncol; 2017 Aug 28; 24(8):2199-2205. PubMed ID: 28204963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.